Search
Showing results for "clinical trials"
Combination antibiotic therapy with an antitoxin agent, such as clindamycin, is included in some guidelines for severe, toxin-mediated Staphylococcus aureus infections. The evidence to support this practice is currently limited to in vitro, animal and observational human case-series data, with no previous randomized controlled trials (RCTs).
The monoclonal antibody, palivizumab is licensed for use in high-risk infants to prevent severe illness caused by respiratory syncytial virus (RSV). The level of its use and compliance with current jurisdictional guidelines which were amended in 2010, is unknown.
Palivizumab appeared effective for reducing virologically confirmed respiratory syncytial virus in this high-risk cohort
To assess the relative effectiveness of topical versus systemic antibiotics for people with chronic suppurative otitis media
Vitamin D status in early life has been linked to the risk of allergic disease in multiple observational studies.
Dr Janessa Pickering is a research microbiologist with expertise in the molecular diagnostics and host pathogen interactions of upper respiratory tract pathogens that cause disease in children.
What would you discover to help a child? At The Kids, our researchers are committed to Autism research that makes a real difference.
The Rio Tinto Children’s Diabetes Centre; a JDRF Global Centre of Excellence announces inaugural funding for researchers dedicated to type 1 diabetes.
The DiabHQ Patient Portal app is now available to WA children and families living with Type 1 diabetes.
We assessed the utility of routine viral surveillance for cytomegalovirus, Epstein–Barr virus and human adenovirus in children <16 years, undergoing autologous stem cell transplantation (ASCT) at a single centre over a 10-year period. A total of 85 ASCT were performed in 65 patients.